The WonderBiotics Philosophy: Why We Do What We Do and How We Think About Gut Health

An honest look at the supplement industry's credibility gap, the gut science we believe in, and the standards we hold ourselves to.

Quick Summary

WonderBiotics exists because the supplement industry has a credibility problem. Current research supports how important the gut microbiome is to our health. But the supplement industry can be the wild west. A 2018 JAMA Network Open analysis of sports supplements found 89 percent were inaccurately labelled and 12 percent contained ingredients prohibited by the FDA, and a 2023 JAMA analysis of popular supplements found only 11 percent contained exactly what their labels claimed.^1,2 The gut microbiome, meanwhile, has been robustly researched, and we know there are bidirectional connections to the immune system, the brain, and metabolic function.^3,4,5 This article is to help you understand how we at WonderBiotics think about gut health and the standards we hold ourselves to: numbered strains with documented evidence, transparent CFU dosing at end of shelf life, no unlabeled "proprietary blends", GMP manufacturing, third-party testing, and a Certificate of Analysis available for any batch we sell. We arenn't saying we're perfect, but the structural problem in the industry calls for brands that takes transparency and evidence seriously. We intend to be that brand.

Key Terms

DSHEA (Dietary Supplement Health and Education Act, 1994): The federal law defining how supplements are regulated in the United States. Manufacturers do not need to prove safety or efficacy before marketing.

Strain specificity: The scientific principle that a probiotic's effects are tied to the specific bacterial strain, not the species name alone. Lactobacillus rhamnosus GG and Lactobacillus rhamnosus generic are not interchangeable.

Certificate of Analysis (COA): A per-batch laboratory document confirming a production run meets identity, purity, potency, and contaminant standards.

GMP (Good Manufacturing Practice): Federal regulations under 21 CFR Part 111 governing supplement manufacturing process, ingredient identity, purity, and documentation.

GALT (Gut-Associated Lymphoid Tissue): The immune tissue embedded in the gut wall, the largest single concentration of immune-active tissue in the body.

The Industry's Credibility Problem

The dietary supplement industry in the United States operates under the 1994 Dietary Supplement Health and Education Act, usually shortened to DSHEA. Under DSHEA, manufacturers do not need to demonstrate safety or efficacy to the FDA before bringing a product to market. The agency's enforcement is largely post-market, which means problems are addressed after consumers have encountered them, not before.

The visible result of this regulatory architecture is a category with serious label-accuracy and ingredient-honesty problems. A 2018 JAMA Network Open analysis of sports supplements found that approximately 89 percent of products examined were inaccurately labelled, and 12 percent contained ingredients prohibited by the FDA.¹ A separate 2023 JAMA analysis tested 60 popular supplements and found that only 11 percent contained exactly what their labels claimed; 40 percent were missing one of their listed ingredients entirely.² Independent industry trend reporting has documented the same pattern: a fast-growing category, weak pre-market oversight, and a credibility gap that consumers can feel even when they cannot articulate it.⁶

The category is not unregulated. That framing is technically inaccurate and worth correcting. There are GMP requirements under 21 CFR Part 111, the FTC enforces advertising standards, and the FDA pursues individual products it identifies as adulterated or misbranded. The accurate way to describe the situation is insufficient pre-market oversight, not absence of regulation.

The gap that creates is the one WonderBiotics was built to close. Not by claiming to have solved it, but by holding ourselves to standards that go meaningfully beyond the regulatory minimum.

Why Gut Health Is the Foundation, Not a Marketing Category

Scientists are constantly uncovering new ways the gut microbiome keeps us healthy. The science is strong, if not constantly evolving, and the public conversation is still catching up. Most of what comes next is about getting the framing right.

The gut microbiome is now widely recognized as a major regulator of human physiology. It influences the immune system, the brain, metabolic function, and skin health, through mechanisms that are increasingly well-described in peer-reviewed literature.^3,4,5 A 2022 review in Gut (BMJ) summarizes the mechanistic insights connecting microbiome composition to metabolic and immune regulation; reviews in Physiological Reviews and Nature have done the same for the gut-brain axis.^3,4,9

While there is a lot that we have learned, there's still a lot we dont knnow. This means our philosophy is straightforward. We treat "gut health" as the systems-biology foundation that the rest of human physiology builds on. The four sections that follow walk through what that means specifically: gut-immune, gut-brain, gut-metabolic, and gut-skin. Each connects to a well-established body of research and we only focus on ingredients that have been tested in real people.

The Gut-Immune Connection

The gut hosts more immune machinery than anywhere else in the body.

Gut-associated lymphoid tissue (GALT) makes up approximately 70 percent of the immune system.^7,8 The popular shorthand is "70 percent of your immune system is in your gut". While this isn't a strict anatomical measurement, it is a reasonable approximation of where the body's immune cells reside, in the mucosa of the gut lining. It makes sense if you think about it. The body enlists most of its defenders where it faces the most threats, especially if you're eating two-week old leftovers.

GALT includes specialized immune cells that sample pieces of the microbes in your gut, and producing antibodies in response. These structures are the body's main interface with the largest collection of foreign material it ever encounters: the gut microbiome itself, plus everything that passes through it. The microbiome has been your immune system's training grounds since infancy. A diverse, balanced microbiome helps the immune system distinguish commensal or helpful microbes (to be left alone) from pathogens (to be attacked).

The connection is real. Now the trick is understanding which microbes can help improve your gut health. This depends on exactly the species of those microbes (the strain) and how much (the dose). That means it is important to focus on studies that track strain-specific evidence rather than as a general "lactobacillus boost your immunity" claim.

The Gut-Brain Conversation

The gut and the brain are connected. The connection is bidirectional, mechanistically well-supported, and can have a modest effect on your mood along with a healthy diet and sleep.

A 2019 review in Physiological Reviews established the contemporary framing of the microbiota-gut-brain axis as a mature research area, drawing on multiple lines of evidence (vagal signaling, neuroactive metabolites, immune cell traffic, hormonal communication).³ A 2024 review in Nature updated this picture and surveyed the therapeutic implications.⁴ The basic claim that the gut microbiome influences brain function and the brain influences gut function is well-anchored.

What is not always well-anchored is the marketing-friendly conclusion that follows. While the microbiome can indeed impact your mood, the specific strain used will have a massive impact and generic types of microbes just doesn't cut it. The mechanism is real; the clinical interventions for mood and mental health using probiotic supplementation are early-stage, with effects that are typically modest, strain-specific, and most pronounced in patients with existing symptoms. We are excited to provide products that use specific pre and probiotic mixes that target the gut-brain axis and are focused on helping you fight cravings, improve gut regularity, and tackle specific women's health challenges.

For deeper gut-anatomy and gut-brain content, including the vagus nerve, the enteric nervous system, and the documented but contested gut-serotonin claim, see our companion article How the Gut Works: A Science-Based Guide to the Body's Most Underrated Organ.

The Gut-Metabolic and Gut-Skin Connections

Two more system-health connections are worth naming carefully.

Gut and metabolic health. Gut dysbiosis is consistently associated with obesity and type 2 diabetes in human observational studies and a growing body of mechanistic work.¹⁰ Short-chain fatty acids produced by gut bacteria fermenting dietary fiber play a documented role in glucose regulation and inflammation. The causal direction (does dysbiosis cause metabolic disease, or does metabolic disease produce dysbiosis, or both?) is still being worked out. The honest framing is that the association is robust and the mechanism is plausible; the clinical translation of microbiome-targeted interventions for weight or blood-sugar outcomes is real but bounded by what specific strains have been studied for specific conditions in specific populations. It's likely that gut microbes play a part in the equation, even if they are not the whole picture.

Gut and skin. Studies have found associations between gut dysbiosis and several inflammatory skin conditions, supported by both observational and mechanistic research.⁵ A 2018 review in Frontiers in Microbiology described the gut-skin axis as a documented bidirectional system, and subsequent reviews have extended the framing.¹¹ The clinical evidence for probiotic supplementation in the gut specifically as a skin treatment is early-stage; we will not pretend otherwise.

In both cases, we acknowledge that the systems are connected. The mechanism is real. The translation to specific products and outcomes is calibrated to the strain-and-condition-specific evidence, not to the broader system claim.

Why Strain Specificity Matters

This is the most consequential single concept in probiotic science, and the one most often mishandled by the industry.

Probiotic effects are simultaneously strain-specific, symptom-specific, dose-specific, and patient-specific. A 2018 systematic review of 228 trials, published as Hempel et al. in PMC, found strong evidence supporting both strain-specificity and disease-specificity of probiotic efficacy.¹² The International Scientific Association for Probiotics and Prebiotics (ISAPP) formally states that effects observed with one strain cannot be extrapolated to another.¹³

The clearest worked example of this principle is Lactobacillus rhamnosus GG (often shortened to LGG). LGG has demonstrated efficacy for prevention of antibiotic-associated diarrhea in children, with meta-analytic relative risk reductions in that specific population for that specific condition. That finding does not generalize to adults, to other digestive conditions, to immunity broadly, or to any other strain in the Lactobacillus rhamnosus species. Two strains of the same species can have entirely different documented properties.

The label implication is direct. A product label that says "Lactobacillus rhamnosus, 5 billion CFU" tells you almost nothing useful, because the species name alone does not carry the clinical evidence. The label that says "Lactobacillus rhamnosus GG (ATCC 53013), 5 billion CFU per dose at end of shelf life" tells you exactly what you have and lets you check it against the published evidence.

This is why our products are labeled at the strain level, with specific strain designations and CFU per strain. The principle is not proprietary to us. It is a category-level scientific standard that the industry has been slow to adopt. That's why we only use numbere strains like B420 and HN019 that have specifically been tested in humans so they work for you.

CFU Count Is Not the Quality Signal

We've discussed strain specificity, now let's talk colony forming units or CFUs.

Colony Forming Units (CFU) measure how many live bacteria are in a dose. While it seems like "more is always better", this is often misleading. If you have a city with 100 available houses, you wouldn't want to force 10,000 new people in because they'd either overpopulate the city or just move right on without doing anything. The right strain at the right dose is critical; adding more CFUs of the wrong strain does not produce additive benefit. Effective doses in clinical trials have ranged across roughly four orders of magnitude depending on strain and indication, from approximately 10⁸ to 10¹¹ CFU per day.^14,13. We ensure that the CFU amount used in the clincal trials matches our formulas, so you get the right microbes at the right amounts.

A second piece of the same problem is ""proprietary blend"" labeling. A label that lists multiple strains under a single combined CFU total without disclosing individual strain doses cannot be evaluated for clinical relevance. Proprietary blends are legal under DSHEA. They are also routinely used to obscure under-dosing of clinically validated strains in favor of larger amounts of cheaper, less-studied ones. Our products do not use proprietary blends; every strain is named, and every strain has its own CFU dose listed at end of shelf life.

The end-of-shelf-life detail is its own quiet point. CFU at manufacture is the number a marketer wants on a label, because it is highest. CFU at end of shelf life is the number a consumer actually receives in the last serving they take from the bottle. Listing the latter is more honest, harder, and the standard we hold ourselves to.

The Standards We Hold Ourselves To

The framework we apply to our work, in plain language, is this. Every product we sell lists each strain at the strain level, with the genus, species, and strain designation, and lists individual CFU per strain at end of shelf life. We do not use proprietary blends. We manufacture under cGMP standards under 21 CFR Part 111, we use third-party testing for label accuracy and contaminant limits, and we make a per-batch Certificate of Analysis available on request for any product we sell.^15,16 The strains we choose are selected for documented evidence in the use cases the products are designed for.

None of this claims our products are clinically proven for any specific outcome. The standards listed here address quality and transparency, not efficacy. They are the floor we hold ourselves to, not the ceiling. We will not link to any product, ours or anyone else's, that does not meet those standards on its public product page (strain designation, end-of-shelf-life CFU, no proprietary blends, third-party testing visible, COA available).

For the broader picture of what we make, see our product range and the Lab of Biotics page describing our manufacturing approach.

Lifestyle First: Supplements Are Adjuncts

While probiotics can have an important impact on your health, they are supplements, not magic bullets.

Diet, sleep, stress, and exercise all measurably shape gut microbiome composition and function. Fiber-rich diets favor short-chain fatty acid-producing bacteria; high-fat, high-sugar diets reduce microbial diversity. Sleep restriction has been shown to alter microbial composition in ways associated with metabolic risk, though the long-term human evidence is still developing.¹⁷ Stress has documented effects on the gut-brain axis and on microbiome diversity, summarized clearly in Stanford Lifestyle Medicine's overview of stress and the microbiome.¹⁸ Aerobic exercise is associated with increased microbial diversity and short-chain fatty acid-producing bacteria; the human trial data is heterogeneous and the effect size depends on context.¹⁹

The implication is that no probiotic product, ours or anyone else's, can do all the work that lifestyle does. A probiotic at any dose, with any strain set, in the most transparent label imaginable, sits inside a wider system. The wider system is mostly built from the unglamorous inputs: how you eat, how you sleep, how you manage chronic stress, how often you move. We say that out loud, even in an article about our own work.

Practical Takeaways: How to Evaluate Any Probiotic

A short list of questions to ask of any probiotic product you consider, including ours.

• Are strains named at the strain level? Genus, species, and strain designation (for example, Lactobacillus rhamnosus GG, ATCC 53013), not just genus or species.
• Is each strain dosed individually, with CFU per strain at end of shelf life? Not at manufacture. Not as a single combined CFU total under a proprietary blend.
• Is there third-party testing? USP, NSF, or comparable independent verification of label accuracy and contaminant limits.
• Is a Certificate of Analysis available? Trustworthy manufacturers provide per-batch COAs on request. Refusal or inability to provide one is a meaningful signal.
• Does the brand acknowledge limits? Effects in probiotic science are typically modest, strain-specific, and condition-specific. A brand willing to teach the limits is a brand more likely to be honest about the positives.
• Does the brand respect lifestyle? Probiotics that work alongside diet, sleep, stress management, and movement deserve the framing of "adjunct"; probiotics framed as replacements for those inputs are overpromising.
• Are the strains chosen for documented evidence? Strain-condition pairings should map to published research. "Proprietary formulation" is not, on its own, evidence.

The Bigger Picture

The case for taking the supplement industry seriously is not that every brand is dishonest. It is that the regulatory architecture makes it hard for consumers to tell the careful brands from the careless ones, and the marketing language across the category is largely indistinguishable from one to the next. WonderBiotics exists because the gut microbiome is genuinely worth caring about and the supplement category is genuinely worth fixing, and we believe both of those things require the same response: evidence-anchored claims, transparent standards, and a willingness to talk about what we do not yet know.

The philosophy is not complicated. Take the science seriously. Label products honestly. Treat customers as adults. Build the brand on standards that earn trust over time, not on superlatives that compress trust into a slogan. We will not always get every detail right. We will keep showing our work. That is the version of "gut health brand" the industry needs, and it is the version we are trying to be.

Related Reading

• For the deeper anatomy and physiology behind the gut-as-foundation framing, read How the Gut Works: A Science-Based Guide to the Body's Most Underrated Organ.
• For the longer-form industry critique, see Do Supplements Actually Work? An Honest Look at the $200 Billion Industry.
• For a closer look at probiotics specifically, including how to evaluate strain claims, read What Are Probiotics? Benefits, Risks, and How to Choose the Right Supplement.
• For a step-by-step on the label questions covered in the practical takeaways, see How to Read a Probiotic Label.
• For the foundational microbiome primer, try Understanding the Human Microbiome.

References

1. Khan H, et al. Sports supplements labeling study (analyzed via University of Mississippi reporting); 89 percent of sports supplements inaccurately labelled. JAMA Network Open. 2018. https://olemiss.edu/news/2023/08/sports-supplements-labeling-study/
2. JAMA. Most dietary and sports supplements don't accurately label ingredients (60-supplement test, only 11 percent containing exactly what their labels claimed). Reported via MMM-Online. 2023. https://www.mmm-online.com/home/channel/jama-most-dietary-and-sports-supplements-dont-accurately-label-ingredients/
3. Cryan JF, et al. The Microbiota-Gut-Brain Axis. Physiological Reviews. 2019. https://journals.physiology.org/doi/abs/10.1152/physrev.00018.2018
4. Wang Y, Wang K. Microbiota-gut-brain axis and its therapeutic applications. Nature / Signal Transduction and Targeted Therapy. 2024. https://www.nature.com/articles/s41392-024-01743-1
5. Salem I, et al. The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Frontiers in Microbiology. 2018. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2018.01459/full
6. Global Wellness Summit. Trend: Finally, Some Transparency Into Supplements. 2025. https://www.globalwellnesssummit.com/trendium/trend-finally-some-transparency-into-supplements/
7. UCLA Health (Heber & Jacobs). If you want to boost immunity, look to the gut. 2021. https://www.uclahealth.org/news/article/want-to-boost-immunity-look-to-the-gut
8. InnerBuddies. Why 70% of your immune system is in your gut: what the figure actually means. https://www.innerbuddies.com/blogs/gut-health/is-70-percent-of-your-immune-system-in-your-gut
9. Carabotti M, et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology / PMC. 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4367209/
10. Cani PD, et al. Gut microbiome and health: mechanistic insights. Gut (BMJ). 2022. https://gut.bmj.com/content/71/5/1020
11. De Pessemier B, et al. Gut-Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions. Microorganisms / PMC. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC7916842/
12. Hempel S, Newberry SJ, Maher AR, et al. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: Systematic Review and Meta-Analysis. Frontiers in Medicine / PMC. 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC5949321/
13. International Scientific Association for Probiotics and Prebiotics (ISAPP). Dispelling Probiotic Myths. 2019. http://isappscience.org/wp-content/uploads/2019/04/Dispelling-Probiotic-Myths.pdf
14. NIH Office of Dietary Supplements. Probiotics: Health Professional Fact Sheet. 2026. https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
15. Trust Transparency Center. Regulations and Best Practices in Quality Control: Testing and Testing Verification. https://trusttransparency.com/regulations-and-best-practices-in-quality-control-testing-and-testing-verification/
16. Banned Substances Control Group (BSCG). Proof, Limits, Myths of GMP Certified Supplements. https://www.bscg.org/blogs/single/gmp-certified-supplements-proof-limits-myths
17. Smith RP, et al. Impact of Food Intake and Sleep Disturbances on Gut Microbiota. PMC. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11531926/
18. Stanford Lifestyle Medicine. Stress and the Microbiome. 2025. https://lifestylemedicine.stanford.edu/stress-and-the-microbiome/
19. Oke MO, et al. A systematic review on the effects of exercise on gut microbial composition. Frontiers in Physiology. 2023. https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2023.1292673/full